These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A CoMFA study of COX-2 inhibitors with receptor based alignment. Datar PA; Coutinho EC J Mol Graph Model; 2004 Dec; 23(3):239-51. PubMed ID: 15530820 [TBL] [Abstract][Full Text] [Related]
10. QSAR analysis of cyclooxygenase inhibitor using particle swarm optimization and multiple linear regression. Lü JX; Shen Q; Jiang JH; Shen GL; Yu RQ J Pharm Biomed Anal; 2004 Jun; 35(4):679-87. PubMed ID: 15193712 [TBL] [Abstract][Full Text] [Related]
11. Computational studies of COX-2 inhibitors: 3D-QSAR and docking. Kim HJ; Chae CH; Yi KY; Park KL; Yoo SE Bioorg Med Chem; 2004 Apr; 12(7):1629-41. PubMed ID: 15028256 [TBL] [Abstract][Full Text] [Related]
12. [Three dimensional quantitative structure-activity relationship of heterocyclic-compounds with di-tert-bultylphenyl inhibitors]. Bai AP; Guo ZR; Chu FM Yao Xue Xue Bao; 2001 May; 36(5):347-50. PubMed ID: 12584856 [TBL] [Abstract][Full Text] [Related]
13. 2D QSAR consensus prediction for high-throughput virtual screening. An application to COX-2 inhibition modeling and screening of the NCI database. Baurin N; Mozziconacci JC; Arnoult E; Chavatte P; Marot C; Morin-Allory L J Chem Inf Comput Sci; 2004; 44(1):276-85. PubMed ID: 14741037 [TBL] [Abstract][Full Text] [Related]
14. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists. Roy K; Leonard JT J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912 [TBL] [Abstract][Full Text] [Related]
15. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools. Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923 [TBL] [Abstract][Full Text] [Related]
16. Exploration of physicochemical properties and molecular modelling studies of 2-sulfonyl-phenyl-3-phenyl-indole analogs as cyclooxygenase-2 inhibitors. Gupta AK; Gupta RA; Soni LK; Kaskhedikar SG Eur J Med Chem; 2008 Jun; 43(6):1297-303. PubMed ID: 17714833 [TBL] [Abstract][Full Text] [Related]
17. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation. Zambre AP; Ganure AL; Shinde DB; Kulkarni VM J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894 [TBL] [Abstract][Full Text] [Related]
19. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834 [TBL] [Abstract][Full Text] [Related]
20. Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method. Michaux C; de Leval X; Julémont F; Dogné JM; Pirotte B; Durant F Eur J Med Chem; 2006 Dec; 41(12):1446-55. PubMed ID: 17030482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]